Aumet

Aumet

closed

Aumet allows medical manufacturers and distributors to connect and share hospital inquiries and business news with each other.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

Valuation: €0.0

round
*

$7.0m

Early VC
Total Funding000k
Notes (0)
More about Aumet
Made with AI
Edit

Aumet operates as a business-to-business healthcare technology platform, initially founded in the United States in 2016 and now headquartered in Riyadh, Saudi Arabia. The company was established by co-founders including Yahya Aqel, who serves as the CEO, and Shahed Jaber. Aqel, a biomedical engineer and serial entrepreneur with over 15 years in health tech, guides the company's mission to improve the healthcare industry's efficiency through technology.

The firm's core business revolves around a digital marketplace that connects pharmaceutical manufacturers, distributors, and healthcare providers, primarily pharmacies. Serving clients in Saudi Arabia, Jordan, and Egypt, Aumet facilitates the procurement process for over 10,000 pharmacies. The business model is designed to streamline operations for both sides of the transaction; it provides a platform for manufacturers and distributors to list their products and expand their reach, while offering pharmacies an efficient tool for ordering and inventory management.

Aumet's main offering is its AI-enabled platform, which includes the "Aumet Marketplace" mobile application and an enterprise resource planning (ERP) system. The marketplace allows pharmacists to order medicines, cosmetics, and medical supplies directly from various distributors. Key features of the platform include predictive analytics to forecast product procurement, which helps pharmacies manage stock levels and reduce costs. The system also offers auto inventory management with real-time ERP integration, stock auto-replenishment, and multiple payment options. By digitizing the ordering and payment cycle, Aumet aims to increase transparency and efficiency in the pharmaceutical supply chain.

Since its inception, Aumet has secured a total of $8.25 million in funding over four rounds. A significant recent round was a $7 million Pre-Series A in March 2023, with participation from investors like Tokyo-based AAIC, Swiss PE firm AIJ Holdings, and early backer Shorooq Partners. This capital is being used to further develop its AI capabilities and expand its network of pharmacies.

Keywords: B2B healthcare, pharmaceutical marketplace, supply chain management, health-tech, pharmacy procurement, inventory management, digital health, predictive analytics, medical distribution, ERP systems

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Aumet

Edit
Uniorders
ACQUISITION by Aumet Oct 2020
Platform One
ACQUISITION by Aumet Dec 2021